HNB
MDCO

Huntington National Bank’s Medicines Co MDCO Stock Holding History

Huntington National Bank’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-228
Closed -$6K – 1750
2016
Q1 		$6K Buy
+228
New +$7.45K ﹤0.01% 1553
2015
Q4 		– Sell
-158
Closed -$6K – 1736
2015
Q3 		$6K Sell
158
-82
-34% -$2.88K ﹤0.01% 1500
2015
Q2 		$7K Buy
240
+12
+5% +$334 ﹤0.01% 1551
2015
Q1 		$6K Buy
+228
New +$6.4K ﹤0.01% 1562

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Huntington National Bank's MDCO Position: Q2 2016 in Review

Huntington National Bank sold out of Medicines Co (MDCO) in Q2 2016, closing a stake of 228 shares — an estimated $6K sold.

Huntington National Bank first reported a position in MDCO in Q1 2015 and held it in 4 quarters. The position peaked at $7K in Q2 2015. 190 funds tracked by Wall St. Rank hold MDCO as of Q2 2016.

  • Huntington National Bank reported no remaining Medicines Co position as of Q2 2016 after selling out during the quarter.
  • Huntington National Bank sold 228 Medicines Co shares in Q2 2016, an estimated $6K.
  • Huntington National Bank first reported a position in Medicines Co in Q1 2015 and held it in 4 quarters.
  • Huntington National Bank's Medicines Co position peaked at $7K in Q2 2015.
  • 190 funds tracked by Wall St. Rank held Medicines Co as of Q2 2016.

Based on Huntington National Bank's 13F filing for Q2 2016, filed 25 Jul 2016.